Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox 4 like 12 (DUX4L12) is a human pseudogene closely related in sequence to the Double homeobox 4 (DUX4) gene, which encodes a functional transcription factor. DUX4 is involved in early embryonic gene regulation and is implicated in diseases including facioscapulohumeral muscular dystrophy and certain cancers[1][7][4][5]. However, DUX4L12 itself is classified as a pseudogene and is not known to be transcribed or translated into a functional protein. It does not have a molecular or therapeutic role in human biology and should not be conflated with DUX4, the active transcription factor. Any drug discovery or disease research relevance should instead focus on DUX4 rather than DUX4L12[3][6]. If information about DUX4 (Double homeobox 4), the functional transcription factor, is desired, please specify, as it has established roles in human disease[1][7][4][5][6].
Not applicable. Drugs and interventions targeting DUX4L12 have not been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox 4 like 12 (pseudogene) (DUX4L12).